Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial.
Martín-Ontiyuelo C, Rodó-Pin A, Echeverría-Esnal D, Admetlló M, Duran-Jordà X, Alvarado M, Gea J, Barreiro E, Rodríguez-Chiaradía DA. Martín-Ontiyuelo C, et al. Among authors: duran jorda x. Arch Bronconeumol. 2022 Oct;58(10):689-698. doi: 10.1016/j.arbres.2021.08.011. Epub 2021 Sep 3. Arch Bronconeumol. 2022. PMID: 35312562 Clinical Trial. English, Spanish.
Risk Factors for Amoxicillin-Clavulanate Resistance in Community-Onset Urinary Tract Infections Caused by Escherichia coli or Klebsiella pneumoniae: The Role of Prior Exposure to Fluoroquinolones.
Martínez-Casanova J, Gómez-Zorrilla S, Prim N, Dal Molin A, Echeverría-Esnal D, Gracia-Arnillas MP, Sendra E, Güerri-Fernández R, Durán-Jordà X, Padilla E, Horcajada JP, Grau S, Proa-Psmar Group OBOT. Martínez-Casanova J, et al. Antibiotics (Basel). 2021 May 14;10(5):582. doi: 10.3390/antibiotics10050582. Antibiotics (Basel). 2021. PMID: 34069184 Free PMC article.
Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study.
López Montesinos I, Gómez-Zorrilla S, Palacios-Baena ZR, Prim N, Echeverria-Esnal D, Gracia MP, Montero MM, Durán-Jordà X, Sendra E, Sorli L, Guerri-Fernandez R, Padilla E, Grau S, Horcajada JP; PROA PSMAR group. López Montesinos I, et al. Infect Dis Ther. 2022 Feb;11(1):335-350. doi: 10.1007/s40121-021-00570-z. Epub 2021 Dec 3. Infect Dis Ther. 2022. PMID: 34860333 Free PMC article.
Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19.
Badenes Bonet D, Caguana Vélez OA, Duran Jordà X, Comas Serrano M, Posso Rivera M, Admetlló M, Herranz Blasco A, Cuadrado Godia E, Marco Navarro E, Martin Ezquerra G, Pineiro Aguin Z, Cumpli Gargallo MC, Gonzalez Garcia JG, Balcells Vilarnau E, Rodriguez Chiaradia D, Castells X, Gea J, Horcajada JP, Villar-García J; MAR Post-COVID-19 Unit. Badenes Bonet D, et al. Among authors: duran jorda x. J Clin Med. 2023 Jun 20;12(12):4158. doi: 10.3390/jcm12124158. J Clin Med. 2023. PMID: 37373850 Free PMC article.
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria.
Curto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G, Cubiró X, Bonfill-Ortí M, Garcias-Ladaria J, Villar M, García-Navarro X, Bielsa-Marsol I, Vilavella M, Aparicio G, Baliu-Piqué C, Álvarez A, Lamas-Domenech N, Duran-Jordà X, Serra-Baldrich E, Giménez-Arnau A. Curto-Barredo L, et al. Br J Dermatol. 2018 Jul;179(1):210-212. doi: 10.1111/bjd.16379. Epub 2018 Apr 25. Br J Dermatol. 2018. PMID: 29368377 No abstract available.
Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.
Sendra E, López Montesinos I, Rodriguez-Alarcón A, Du J, Siverio-Parés A, Arenas-Miras M, Cañas-Ruano E, Prim N, Durán-Jordà X, Blasco-Hernando F, García-Alzorriz E, Cots F, Ferrández O, Gómez-Zorrilla S. Sendra E, et al. Among authors: duran jorda x. Antibiotics (Basel). 2022 Oct 29;11(11):1511. doi: 10.3390/antibiotics11111511. Antibiotics (Basel). 2022. PMID: 36358167 Free PMC article.
Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Carballo N, Garcia-Alzórriz E, Ferrández O, Navarrete-Rouco ME, Durán-Jordà X, Pérez-García C, Monfort J, Cots F, Grau S. Carballo N, et al. Front Pharmacol. 2021 Nov 29;12:752879. doi: 10.3389/fphar.2021.752879. eCollection 2021. Front Pharmacol. 2021. PMID: 34912219 Free PMC article.
24 results